US Patent 8206716 Methods of treating with anti-C5/C5a specific antibodies
Patent 8206716 was granted and assigned to Genentech on June, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8206716 Methods of treating with anti-C5/C5a specific antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
